干扰素签名的成员,在多发性硬化症患者的干扰素-β治疗时的一种新的改变相关性
Sarvin Jabbari1, Mohammadali Hosseinpourfeizi1, Reza Safaralizadeh1
1Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.
Current molecular medicine
|October 16, 2023
概括
干扰素β (IFN-β) 治疗增加了多发性硬化症 (MS) 患者的IFI44和MX1基因的表达. 这些基因可能表明患者对IFN-β治疗MS的反应如何.
科学领域:
- 神经免疫学 神经免疫学
- 分子生物学分子生物学
背景情况:
- 多发性硬化症 (MS) 是一种慢性中枢神经系统炎症性疾病,涉及自身免疫.
- I型干扰素 (IFN) 是MS的治疗方案,但患者的反应有所不同.
- 在MS患者中,低I型IFN水平可能会影响免疫控制和治疗疗效.
研究的目的:
- 在接受IFN-β治疗的MS患者中研究IFN调节基因的表达.
- 在多发性硬化症中确定IFN-β治疗反应的潜在生物标志物.
主要方法:
- 横截面研究设计. 截面研究设计.
- 定量逆转录聚合酶连锁反应 (qRT-PCR) 用于测量基因表达.
- 在接受IFN-β治疗的MS患者中检查了IFI44和MX1基因表达.
主要成果:
- 在MS患者中,IFN-β治疗显著上调IFI44和MX1基因表达.
- 与新诊断患者相比,在接受治疗的患者中观察到较高的IFI44和MX1表达.
- 治疗后的IFI44和MX1表达水平可以作为IFN-β响应的指标.
结论:
- IFI44/MX1基因轴在IFN-β治疗后的多发性硬化症调节中发挥作用.
- IFI44和MX1显示出作为预测MS中IFN-β治疗反应的生物标志物的潜力.
- 了解这些基因调节剂可以优化IFN-β治疗MS的策略.
更多相关视频
相关概念视频
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K


